Wei Wang

Title: Wei Wang: Innovator in Drug Formulation

Introduction

Wei Wang is a notable inventor based in Cary, NC (US), recognized for his contributions to the field of drug formulation. He holds 2 patents that focus on innovative methods for encapsulating hydrophobic pharmaceutically active agents, particularly in cancer treatment.

Latest Patents

Wei Wang's latest patents include a groundbreaking formulation based on particulates comprising a polysaccharide-vitamin conjugate. This formulation provides a novel approach for administering pharmacologically active reagents. The particulates are formed from a biodegradable polymer, such as dextran, linked to a vitamin like folic acid. The encapsulation of hydrophobic agents, such as the anti-cancer drug paclitaxel, occurs within the core of the particulate, enhancing the delivery and efficacy of the treatment. The patent also outlines processes for making and using these particulates, along with methods for cancer diagnosis and treatment.

Career Highlights

Throughout his career, Wei Wang has worked with several companies, including Zy Therapeutics, Inc. and U.S. Tianyou Capital Corp. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Wei Wang has collaborated with notable colleagues in his field, including Jun Li and Jian Bao. Their combined efforts have further advanced the research and application of innovative drug formulations.

Conclusion

Wei Wang's work in drug formulation, particularly in the context of cancer treatment, showcases his innovative spirit and dedication to improving healthcare solutions. His patents reflect significant advancements in the field, making him a key figure in pharmaceutical innovation.